CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 86.30
-1.70 (-1.93%)
At close: Mar 27, 2026
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 8.87 billion as of March 27, 2026. Its market cap has increased by 1.53% in one year.
Market Cap
8.87B
Enterprise Value
9.14B
Revenue
1.82B
Ranking
n/a
PE Ratio
19.18
Stock Price
86.30
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 8.87B, an increase of 18.76%. That is a compound annual growth rate of 1.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.87B | -4.11% |
| Dec 31, 2025 | 9.25B | 11.39% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 588.47B |
| China Steel | 298.74B |
| Formosa Plastics | 298.55B |
| Formosa Chemicals & Fibre | 258.82B |
| Chia Hsin Cement | 9.06B |
| China Steel Structure | 8.97B |
| Taiwan Hopax Chemicals Manufacturing | 8.96B |
| LCY Technology | 8.90B |